The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim-Reference-Cited by-同舟云学术

The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim

Published:2024-02-06 Issue:4 Volume:204 Page:1143-1145
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Al‐Samkari Hanny¹^ORCID,Schifferli Alexandra²^ORCID,Gonzalez‐Lopez Tomas J.³^ORCID

Affiliation:

1. Division of Hematology Oncology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

2. Department of Hematology/Oncology University Children's Hospital Basel Basel Switzerland

3. Hematology Department Hospital Universitario de Burgos Burgos Spain

Abstract

Immune thrombocytopenia refractory to multiple thrombopoietin receptor agonists remains a challenging clinical problem. This commentary discusses and contextualizes the recent report on this entity from Moulis and colleagues, and how to move forward with these patients.Commentary on: Moulis et al. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France Registry. Br J Haematol 2024;204:1476‐1482.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19327

Reference15 articles.

1. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry

2. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

3. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

4. An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia

5. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France;La Revue de Médecine Interne;2024-09